During the past decade, Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia" are "Epilepsy, Partial Seizures" (2 trials), "Epilepsy, Primary Generalized Tonic-Clonic Seizures" (1 trials) and "Partial Onset Seizures" (1 trials). Many other conditions were trialed in "Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia" in a lesser frequency.

Most popular intervention types in "Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Pregabalin" (1 trials), "Pregabalin Dose Level 1" (1 trials), "Pregabalin Dose Level 2" (1 trials) and "Pregabalin add-on therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".